<DOC>
	<DOCNO>NCT00818090</DOCNO>
	<brief_summary>To assess efficacy safety regimen previously untreated , unresectable invasive thymoma thymic carcinoma</brief_summary>
	<brief_title>Paclitaxel Cisplatin Thymic Neoplasm</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologically cytologically confirm invasive thymoma thymic carcinoma unresectable tumor : either local invasion , distant metastasis , recur ( assessed investigator ) previous systemic treatment invasive thymoma thymic carcinoma least one measurable lesion RECIST criterion 18 year old old ECOG performance status 0 , 1 , 2 adequate lab . finding neutrophil ≥ 1.5 x 10^9/L platelet ≥ 75 x 10^9/L hemoglobin ≥ 9.0 g/dL bilirubin ≤ 1.5 x upper normal limit AST , ALT ≤ 2.5 x upper normal limit Alkaline phosphatase ≤ 2.5 x upper normal limit ( liver metastasis , ≤ 5 x upper normal limit ) serum creatinine ≤ 1.0 x upper normal limit serum creatinine &gt; 1.0 x upper normal limit , creatinine clearance ≥ 60 mL/min patient agree write , informed consent malignancy ( exception : nonmelanoma skin cancer , cervical carcinoma situ , cancer without evidence 5 year since curative resection ) active bacterial infection history clinical trial investigational drug within 30 day radiotherapy thoracic mediastinal area ( area radiotherapy permit ) pregnant , lactate woman patient organ transplantation peripheral neuropathy , grade 2 great severe , medical condition unstable cardiac disease despite adequate management myocardial infarction within 6 month active ulcer disease refractory medication chronic obstructive lung disease require admission treatment within 1 year uncontrolled seizure , cerebral nervous system disorder , psychiatric problem decrease treatment compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>thymic epithelial tumor</keyword>
	<keyword>paclitaxel</keyword>
	<keyword>cisplatin</keyword>
	<keyword>thymic carcinoma</keyword>
	<keyword>invasive thymoma</keyword>
</DOC>